USE OF BLOCKING ANTI-TSH-RECEPTOR-ANTIBODIES IN THE THERAPY OF HYPERTHYREOSES AND MONOCLONAL ANTIBODIES FOR A USE OF THIS TYPE
Use of blocking antibodies against the human TSH receptor (hTSH receptor) or their specifically binding fragments for the treatment of, or for preparation of drugs for the treatment of, hyperthyroidism which is attributable to stimulating autoantibodies against the hTSH receptor (Graves' diseas...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | STRUCK, JOACHIM BERGMANN, ANDREAS MORGENTHALER, NILS, GERNOT JOHNSTONE, ALAN P SHEPHERD, PHILIP S |
| description | Use of blocking antibodies against the human TSH receptor (hTSH receptor) or their specifically binding fragments for the treatment of, or for preparation of drugs for the treatment of, hyperthyroidism which is attributable to stimulating autoantibodies against the hTSH receptor (Graves' disease) or overstimulation of the thyroid gland by endogenous TSH or to activating mutations of the hTSH receptor, and for the treatment of Graves' ophthalmopathy, and specific blocking monoclonal antibodies which recognize the minimum sequence FDSH corresponding to the positions 381 to 384 of the human TSH receptor. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1153039B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1153039B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1153039B13</originalsourceid><addsrcrecordid>eNqNjbEKwjAURbs4iPoP7wcChuLgmKavJhjzQvIcOpUicRIt1Nlvt4UOjg6XC5dzuOvic00I1EDlSJ-tP4HybAUnIyJqDExRzEtFtcUE1gMbnBNVaGfPtAEjmzYipQlQvoYLedKOvHLwozYUQcHyxsYm4EndFqt7_xjzbulNAQ2yNiIPry6PQ3_Lz_zuMEh5KPflsZLlH8gXdEg7EQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF BLOCKING ANTI-TSH-RECEPTOR-ANTIBODIES IN THE THERAPY OF HYPERTHYREOSES AND MONOCLONAL ANTIBODIES FOR A USE OF THIS TYPE</title><source>esp@cenet</source><creator>STRUCK, JOACHIM ; BERGMANN, ANDREAS ; MORGENTHALER, NILS, GERNOT ; JOHNSTONE, ALAN P ; SHEPHERD, PHILIP S</creator><creatorcontrib>STRUCK, JOACHIM ; BERGMANN, ANDREAS ; MORGENTHALER, NILS, GERNOT ; JOHNSTONE, ALAN P ; SHEPHERD, PHILIP S</creatorcontrib><description>Use of blocking antibodies against the human TSH receptor (hTSH receptor) or their specifically binding fragments for the treatment of, or for preparation of drugs for the treatment of, hyperthyroidism which is attributable to stimulating autoantibodies against the hTSH receptor (Graves' disease) or overstimulation of the thyroid gland by endogenous TSH or to activating mutations of the hTSH receptor, and for the treatment of Graves' ophthalmopathy, and specific blocking monoclonal antibodies which recognize the minimum sequence FDSH corresponding to the positions 381 to 384 of the human TSH receptor.</description><edition>7</edition><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050112&DB=EPODOC&CC=EP&NR=1153039B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050112&DB=EPODOC&CC=EP&NR=1153039B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>STRUCK, JOACHIM</creatorcontrib><creatorcontrib>BERGMANN, ANDREAS</creatorcontrib><creatorcontrib>MORGENTHALER, NILS, GERNOT</creatorcontrib><creatorcontrib>JOHNSTONE, ALAN P</creatorcontrib><creatorcontrib>SHEPHERD, PHILIP S</creatorcontrib><title>USE OF BLOCKING ANTI-TSH-RECEPTOR-ANTIBODIES IN THE THERAPY OF HYPERTHYREOSES AND MONOCLONAL ANTIBODIES FOR A USE OF THIS TYPE</title><description>Use of blocking antibodies against the human TSH receptor (hTSH receptor) or their specifically binding fragments for the treatment of, or for preparation of drugs for the treatment of, hyperthyroidism which is attributable to stimulating autoantibodies against the hTSH receptor (Graves' disease) or overstimulation of the thyroid gland by endogenous TSH or to activating mutations of the hTSH receptor, and for the treatment of Graves' ophthalmopathy, and specific blocking monoclonal antibodies which recognize the minimum sequence FDSH corresponding to the positions 381 to 384 of the human TSH receptor.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjbEKwjAURbs4iPoP7wcChuLgmKavJhjzQvIcOpUicRIt1Nlvt4UOjg6XC5dzuOvic00I1EDlSJ-tP4HybAUnIyJqDExRzEtFtcUE1gMbnBNVaGfPtAEjmzYipQlQvoYLedKOvHLwozYUQcHyxsYm4EndFqt7_xjzbulNAQ2yNiIPry6PQ3_Lz_zuMEh5KPflsZLlH8gXdEg7EQ</recordid><startdate>20050112</startdate><enddate>20050112</enddate><creator>STRUCK, JOACHIM</creator><creator>BERGMANN, ANDREAS</creator><creator>MORGENTHALER, NILS, GERNOT</creator><creator>JOHNSTONE, ALAN P</creator><creator>SHEPHERD, PHILIP S</creator><scope>EVB</scope></search><sort><creationdate>20050112</creationdate><title>USE OF BLOCKING ANTI-TSH-RECEPTOR-ANTIBODIES IN THE THERAPY OF HYPERTHYREOSES AND MONOCLONAL ANTIBODIES FOR A USE OF THIS TYPE</title><author>STRUCK, JOACHIM ; BERGMANN, ANDREAS ; MORGENTHALER, NILS, GERNOT ; JOHNSTONE, ALAN P ; SHEPHERD, PHILIP S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1153039B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>STRUCK, JOACHIM</creatorcontrib><creatorcontrib>BERGMANN, ANDREAS</creatorcontrib><creatorcontrib>MORGENTHALER, NILS, GERNOT</creatorcontrib><creatorcontrib>JOHNSTONE, ALAN P</creatorcontrib><creatorcontrib>SHEPHERD, PHILIP S</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>STRUCK, JOACHIM</au><au>BERGMANN, ANDREAS</au><au>MORGENTHALER, NILS, GERNOT</au><au>JOHNSTONE, ALAN P</au><au>SHEPHERD, PHILIP S</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF BLOCKING ANTI-TSH-RECEPTOR-ANTIBODIES IN THE THERAPY OF HYPERTHYREOSES AND MONOCLONAL ANTIBODIES FOR A USE OF THIS TYPE</title><date>2005-01-12</date><risdate>2005</risdate><abstract>Use of blocking antibodies against the human TSH receptor (hTSH receptor) or their specifically binding fragments for the treatment of, or for preparation of drugs for the treatment of, hyperthyroidism which is attributable to stimulating autoantibodies against the hTSH receptor (Graves' disease) or overstimulation of the thyroid gland by endogenous TSH or to activating mutations of the hTSH receptor, and for the treatment of Graves' ophthalmopathy, and specific blocking monoclonal antibodies which recognize the minimum sequence FDSH corresponding to the positions 381 to 384 of the human TSH receptor.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP1153039B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | USE OF BLOCKING ANTI-TSH-RECEPTOR-ANTIBODIES IN THE THERAPY OF HYPERTHYREOSES AND MONOCLONAL ANTIBODIES FOR A USE OF THIS TYPE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T03%3A52%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=STRUCK,%20JOACHIM&rft.date=2005-01-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1153039B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |